NCT04439292 · Interventional trial
Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H)
Overall registry status Active not recruiting
Phase 2
Conditions Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm, Refractory Lymphoma, Refractory Malignant Solid Neoplasm, Refractory Multiple Myeloma
Delaware Valley sites
- ECOG-ACRIN Cancer Research Group · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory